David Nutt
Edmond J. Safra Professor of Neuropsychopharmacology
Key Impact
Leading figure in neuropsychopharmacology and drug policy reform; founder of Drug Science.
Background & Research
David Nutt is an English neuropsychopharmacologist and a leading authority on the effects of drugs on the brain and society. He holds the Edmond J. Safra Chair in Neuropsychopharmacology at Imperial College London and is the founder of Drug Science, an independent body providing evidence-based drug information. His career has focused on addiction, anxiety, and sleep, and he has been a vocal advocate for the therapeutic use of psychedelics and scientific drug policy.
Collaboration Network
97 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Depressive DisordersNeuroimaging & Brain MeasuresAnxiety DisordersHealthy VolunteersMajor Depressive Disorder (MDD)Substance Use Disorders (SUD)Treatment-Resistant Depression (TRD)SchizophreniaSet & SettingPTSDPersonality & Trait FactorsSafety & Risk ManagementAlcohol Use Disorder (AUD)Obsessive-Compulsive Disorder (OCD)Palliative & End-of-Life DistressMedicinal Chemistry & Drug DevelopmentAdolescentsMicrodosingInterpersonal Functioning & Social ConnectednessBipolar DisorderEquity and EthicsEating DisordersChronic PainHealth Economics & ReimbursementOlder AdultsCreativitySuicidalityTobacco/Nicotine Use Disorder (TUD)Headache Disorders (Cluster & Migraine)Implementation & Service DeliveryNeurocognitive DisordersOpioid Use Disorder (OUD)Public Health, Prevention & Behaviour Change